ICUI · NASDAQ · Medical - Instruments & Supplies

ICU Medical

Builds infusion pumps, IV consumables, and vital-care devices for clinical workflows.

$175.10
After-hours close+0.01 (+0.01%)
At close$175.09(−0.01%)

Breakdown13F · Form 4

Institutions 121.22%Insiders 0.94%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 24.99M · Float 24.50M · 98.0% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.3.75M15.02%13FAug 7, 2026
Jupiter Topco LLC2.78M11.13%13FAug 14, 2026
Janus Henderson Group PLC2.47M10.00%13GAug 14, 2025
Vanguard Portfolio Management LLC1.47M5.88%13FAug 13, 2026
Fuller & Thaler Asset Management, Inc.1.30M5.19%13FAug 12, 2026

Institutions13F, as of Jun 30, 2026

292 holders · 30.30M shares · 47 new positions · 168 increased · 81 reduced · 36 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.3.75M15.02%+145.1KAug 7, 2026
Jupiter Topco LLC2.78M11.13%+2.78MnewAug 14, 2026
Vanguard Portfolio Management LLC1.47M5.88%+32.9KAug 13, 2026
Fuller & Thaler Asset Management, Inc.1.30M5.19%+77.6KAug 12, 2026
Vanguard Capital Management LLC1.12M4.49%+11.4KAug 13, 2026
Dimensional Fund Advisors LP1.05M4.21%+69.7KAug 11, 2026
State Street Corp1.02M4.10%+56.3KAug 7, 2026
Schroder Investment Management Group739.1K2.96%+37.9KAug 13, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Janus Henderson Group PLC10.00%2.47M13GAug 14, 2025
Vanguard Portfolio Management5.82%1.46M13GApr 29, 2026
Vanguard Capital Management5.19%1.30M13GApr 30, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Vivek Jaindirector, officer: Chairman and CEO152.3K0.61%Mar 16, 2026
Christian B. Voigtlanderofficer: Chief Operating Officer37.4K0.15%Aug 11, 2026
Virginia Ruth Sanzoneofficer: VP, General Counsel19.5K0.08%May 15, 2026
Daniel Woolsonofficer: VP, GM-Infusion Capital17.1K0.07%Aug 13, 2026
Elisha W. Finneydirector4.9K0.02%Aug 11, 2026
Ben Sousaofficer: Chief Information Officer3.1K0.01%Aug 12, 2026

2 ten-percent owners hold 3.34M shares by Form 4, outside the officers-and-directors figure above · 7 people have not refiled in the last 18 months (939.1K shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 13, 2026
Daniel Woolsonofficer: VP, GM-Infusion Capital
Sale5,417$181.3317,062
Aug 12, 2026
Ben Sousaofficer: Chief Information Officer
Sale2,250$178.323,076
Aug 11, 2026
Christian B. Voigtlanderofficer: Chief Operating Officer
Sale8,929$182.9337,377
Aug 11, 2026
Elisha W. Finneydirector
Sale378$182.484,871
May 22, 2026
Daniel Woolsonofficer: President
Sale2,123$132.2122,479
May 14, 2026
Virginia Ruth Sanzoneofficer: VP, General Counsel
Sale2,447$124.0819,460
May 12, 2026
David C. Greenbergdirector
Sale2,424$122.917,960
Nov 25, 2025
Daniel Woolsonofficer: VP, GM-Infusion Capital
Sale2,897$152.3511,297
Nov 11, 2025
Virginia Ruth Sanzoneofficer: VP, General Counsel
Sale930$142.355,456
Nov 11, 2025
Elisha W. Finneydirector
Sale1,285$140.423,995

CongressHouse and Senate disclosures

Not reported.